Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hematologic Neoplasms 8Leukemia 6Infections 5Mycoses 4Leukemia, Myeloid, Acute 4Invasive Fungal Infections 4Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, Follicular 3Wilms Tumor 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Drug-Related Side Effects and Adverse Reactions 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Sezary Syndrome 1

Interventions

posaconazole 1liposomal amphotericin B 1Voriconazole 1Micafungin 1Fluconazole 1Blood Specimen Collection 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Aspergillosis × Voriconazole × Clear all
NCT01207128 2012-04-20

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

University of Arkansas

Phase 2 Withdrawn

Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡